Evidence map›Paper›PMID 36040180›Full record

ArticleJournal of virology2022

Evidence for Viral mRNA Export from Ebola Virus Inclusion Bodies by the Nuclear RNA Export Factor NXF1.

Lisa Wendt, Janine Brandt, Dmitry S Ushakov, Bianca S Bodmer, Matthew J Pickin, Allison Groseth, Thomas Hoenen

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Comprehensive Multi-Omics Analysis of Muscle Tissue Alterations in MaleInternational journal of molecular sciences · 2025
    Article
  4. Review
  5. Identification of porcine PARP11 as a restricted factor for pseudorabies virus.Frontiers in cellular and infection microbiology · 2024
    Article
  6. Article
  7. NEmerging microbes & infections · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lisa WendtInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institutgrid.417834.d, Greifswald-Insel Riems, Germany.ORCID 0000-0002-0390-5820
Janine BrandtInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institutgrid.417834.d, Greifswald-Insel Riems, Germany.ORCID 0000-0003-3416-302X
Dmitry S UshakovInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institutgrid.417834.d, Greifswald-Insel Riems, Germany.
Bianca S BodmerInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institutgrid.417834.d, Greifswald-Insel Riems, Germany.ORCID 0000-0001-9695-9168
Matthew J PickinInstitute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institutgrid.417834.d, Greifswald-Insel Riems, Germany.ORCID 0000-0003-2528-9560
Allison GrosethInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institutgrid.417834.d, Greifswald-Insel Riems, Germany.ORCID 0000-0001-9528-5130
Thomas HoenenInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institutgrid.417834.d, Greifswald-Insel Riems, Germany.ORCID 0000-0002-5829-6305
Friedrich-Loeffler-Institut · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many negative-sense RNA viruses, including the highly pathogenic Ebola virus (EBOV), use cytoplasmic inclusion bodies (IBs) for viral RNA synthesis. However, it remains unclear how viral mRNAs are exported from these IBs for subsequent translation. We recently demonstrated that the nuclear RNA export factor 1 (NXF1) is involved in a late step in viral protein expression, i.e., downstream of viral mRNA transcription, and proposed it to be involved in this mRNA export process. We now provide further evidence for this function by showing that NXF1 is not required for translation of viral mRNAs, thus pinpointing its function to a step between mRNA transcription and translation. We further show that RNA binding of both NXF1 and EBOV NP is necessary for export of NXF1 from IBs, supporting a model in which NP hands viral mRNA over to NXF1 for export. Mapping of NP-NXF1 interactions allowed refinement of this model, revealing two separate interaction sites, one of them directly involving the RNA binding cleft of NP, even though these interactions are RNA-independent. Immunofluorescence analyses demonstrated that individual NXF1 domains are sufficient for its recruitment into IBs, and complementation assays helped to define NXF1 domains important for its function in the EBOV life cycle. Finally, we show that NXF1 is also required for protein expression of other viruses that replicate in cytoplasmic IBs, including Lloviu and Junín virus. These data suggest a role for NXF1 in viral mRNA export from IBs for various viruses, making it a potential target for broadly active antivirals.

Indexed as

EbolavirusHemorrhagic Fever, EbolaNucleocytoplasmic Transport ProteinsRNA-Binding ProteinsRNA, ViralAntiviral AgentsHumansInclusion Bodies, ViralRNA, MessengerViral ProteinsAntiviral AgentsNucleocytoplasmic Transport ProteinsNXF1 protein, humanRNA-Binding ProteinsRNA, MessengerRNA, ViralViral ProteinsEbola virusfilovirusinclusion bodyJunin virusLloviu virusmRNA exportNXF1replication factory

Identifiers

PMID36040180
PMCPMC9517727
OpenAlexW4293567116

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.